SCPS:OTC-Scopus Biopharma Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.0003

Change

0.00 (0.00)%

Market Cap

USD 0.01M

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
UCBJY UCB SA ADR

-0.51 (-0.56%)

USD 34.50B
UCBJF UCB SA

N/A

USD 34.43B
ARGNF argenx SE

N/A

USD 31.41B
GNMSF Genmab A/S

-7.90 (-2.95%)

USD 17.62B
ZLDPF Zealand Pharma A/S

+5.95 (+4.55%)

USD 9.35B
IVBIY IVBIY

N/A

USD 8.92B
SBMFF Sino Biopharmaceutical Limited

N/A

USD 7.30B
SBHMY Sino Biopharmaceutical Ltd ADR

N/A

USD 7.29B
WXXWY WuXi Biologics (Cayman) Inc

-0.04 (-1.37%)

USD 5.87B
WXIBF WuXi Biologics

N/A

USD 5.87B

ETFs Containing SCPS

IGE 1,000.00 % 0.46 %

N/A

N/A
WTID UBS ETRACS - ProShares Da.. 11.60 % 0.00 %

-0.35 (0.38%)

USD 5.15M
WTIU UBS ETRACS - ProShares Da.. 11.60 % 0.00 %

+0.22 (+0.38%)

USD 8.63M
IOGP:LSE iShares Oil & Gas Explora.. 10.25 % 0.00 %

+0.14 (+0.38%)

N/A
SPOG:LSE iShares V Public Limited .. 10.25 % 0.00 %

+0.50 (+0.38%)

N/A
NRGO 10.00 % 0.00 %

N/A

N/A
NRGZ 10.00 % 0.00 %

N/A

N/A
YGRN 10.00 % 0.00 %

N/A

N/A
IS0D:F iShares Oil & Gas Explora.. 9.84 % 0.00 %

+0.07 (+0.38%)

N/A
FRAK 8.73 % 0.54 %

N/A

N/A
EMXC iShares MSCI Emerging Mar.. 8.11 % 0.41 %

+0.27 (+0.38%)

USD 15.88B
IESU:LSE iShares S&P 500 Energy Se.. 7.90 % 0.00 %

+1.00 (+0.38%)

N/A
QDVF:F iShares S&P 500 Energy Se.. 7.81 % 0.00 %

+0.02 (+0.38%)

N/A
QDVF:XETRA iShares S&P 500 Energy Se.. 7.81 % 0.00 %

+0.03 (+0.38%)

USD 0.98B
FTXN First Trust Nasdaq Oil & .. 7.79 % 0.60 %

+0.22 (+0.38%)

USD 0.18B
XUEN:XETRA db x-trackers MSCI USA En.. 7.19 % 0.00 %

+0.13 (+0.38%)

USD 0.09B
OILD MicroSectorsTM Oil & Gas .. 7.13 % 1.24 %

-0.34 (0.38%)

USD 0.02B
OILU MicroSectorsTM Oil & Gas .. 7.13 % 1.22 %

+0.41 (+0.38%)

USD 0.05B
JHME 6.90 % 0.48 %

N/A

N/A
VDE Vanguard Energy Index Fun.. 6.38 % 0.10 %

+0.73 (+0.38%)

USD 7.79B
DDG 5.83 % 0.95 %

N/A

N/A
DUG ProShares UltraShort Oil .. 5.83 % 0.95 %

-0.11 (0.38%)

N/A
ERYY 4.79 % 0.45 %

N/A

N/A
WNRG:LSE SPDR MSCI World Energy UC.. 4.71 % 0.00 %

+0.37 (+0.38%)

N/A
FCG First Trust Natural Gas E.. 4.55 % 0.60 %

+0.20 (+0.38%)

N/A
XDW0:LSE db x-trackers MSCI World .. 4.53 % 0.00 %

+0.32 (+0.38%)

N/A
XDW0:XETRA db x-trackers MSCI World .. 4.53 % 0.00 %

+0.15 (+0.38%)

USD 1.07B
5MVW:XETRA iShares MSCI World Energy.. 4.53 % 0.00 %

+0.02 (+0.38%)

USD 0.59B
SXLE:LSE SPDR S&P U.S. Energy Sele.. 4.49 % 0.00 %

+0.17 (+0.38%)

N/A
HUL-U:CA 4.46 % 0.00 %

N/A

N/A
HUL:CA 4.46 % 2.20 %

N/A

N/A
XLE Energy Select Sector SPDR.. 4.35 % 0.13 %

+0.48 (+0.38%)

USD 34.66B
NANR SPDR S&P® North American.. 4.30 % 0.35 %

+0.55 (+0.38%)

N/A
GASX 4.29 % 1.01 %

N/A

N/A
ZPDE:XETRA SPDR® S&P® U.S. Energy .. 4.25 % 0.00 %

+0.10 (+0.38%)

USD 0.78B
DIG ProShares Ultra Oil & Gas 3.29 % 0.95 %

+0.39 (+0.38%)

N/A
XOP SPDR® S&P Oil & Gas Expl.. 3.03 % 0.35 %

+1.30 (+0.38%)

N/A
ERX Direxion Daily Energy Bul.. 3.00 % 1.08 %

+0.55 (+0.38%)

N/A
EQRR ProShares Equities for Ri.. 2.85 % 0.35 %

+0.47 (+0.38%)

USD 0.01B
SPGP Invesco S&P 500 GARP ETF 2.04 % 0.36 %

+1.26 (+0.38%)

USD 4.24B
GASL 1.45 % 1.19 %

N/A

N/A
TERM 0.88 % 0.64 %

N/A

N/A
RIRA:CA Russell Investments Real .. 0.60 % 0.00 %

+0.17 (+0.38%)

CAD 0.21B
JIGB 0.39 % 0.14 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

+0.07 (+0.38%)

N/A
BWX SPDR® Bloomberg Internat.. 0.00 % 0.50 %

+0.13 (+0.38%)

N/A
EBND SPDR® Bloomberg Emerging.. 0.00 % 0.41 %

+0.13 (+0.38%)

N/A
ILF iShares Latin America 40 .. 0.00 % 0.48 %

+0.27 (+0.38%)

N/A
MTUM 0.00 % 0.15 %

N/A

N/A
RYE 0.00 % 0.40 %

N/A

N/A
WIP SPDR® FTSE International.. 0.00 % 0.50 %

+0.41 (+0.38%)

N/A
SMRU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

+8.23 (+0.38%)

N/A
SM8T:F Amundi Index Solutions - .. 0.00 % 0.00 %

+2.40 (+0.38%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -99.30% 5% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.30% 5% F 1% F
Trailing 12 Months  
Capital Gain -99.36% 4% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.36% 5% F 2% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -65.66% 1% F N/A F
Dividend Return -65.66% 1% F N/A F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 40.71% 73% C 58% F
Risk Adjusted Return -161.27% 2% F N/A F
Market Capitalization 0.01M 8% B- 4% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.